STOCK TITAN
  1. Home
  2. Financials
  3. HAVAU

Harvard Ave Financials

HAVAU
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Harvard Ave (HAVAU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 7 / 100
Financial Profile 7/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Harvard Ave's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity
43

Harvard Ave's current ratio of 2.34 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Earnings Quality Low Quality
-1.80x

For every $1 of reported earnings, Harvard Ave generates $-1.80 in operating cash flow (-$1.3M OCF vs $729K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
$729K

Harvard Ave reported $729K in net income in fiscal year 2025.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$965K

Harvard Ave held $965K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

HAVAU Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A
Operating Income -$162K N/A N/A N/A -$22K N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A
Net Income $1.1M N/A -$33K+23.2% -$42K-94.1% -$22K N/A -$17K
EPS (Diluted) N/A N/A $-0.01 N/A N/A N/A $0.00

HAVAU Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $148.3M+0.8% $147.1M+6371.3% $2.3M N/A N/A $217K N/A
Current Assets $993K-10.4% $1.1M-41.2% $1.9M N/A N/A $10K N/A
Cash & Equivalents $868K-10.1% $965K-48.2% $1.9M N/A N/A $6K N/A
Inventory N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $152.2M+0.9% $150.8M+6107.5% $2.4M N/A N/A $277K N/A
Current Liabilities $520K+9.7% $474K-80.5% $2.4M N/A N/A $277K N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A
Total Equity -$3.9M-4.4% -$3.7M-2274.7% -$156K-26.3% -$124K-51.9% -$82K-36.5% -$60K-870.2% $8K
Retained Earnings -$3.9M-4.4% -$3.7M-1947.8% -$181K N/A N/A -$85K N/A

HAVAU Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow $8K-98.7% $656K N/A N/A -$20K-308.4% -$5K+17.5% -$6K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow -$8K-100.0% $144.3M N/A N/A $20K N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A

HAVAU Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A -222.4%
Return on Assets 0.8% N/A -1.4% N/A N/A N/A N/A
Current Ratio 1.91-0.4 2.34+1.6 0.78 N/A N/A 0.04 N/A
Debt-to-Equity -39.25+1.3 -40.60-25.1 -15.53 N/A N/A -4.63 N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$3.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Yes, Harvard Ave (HAVAU) reported a net income of $729K in fiscal year 2025.

Harvard Ave (HAVAU) generated -$1.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Harvard Ave (HAVAU) had $147.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Harvard Ave (HAVAU) had a current ratio of 2.34 as of fiscal year 2025, which is generally considered healthy.

Harvard Ave (HAVAU) had a debt-to-equity ratio of -40.60 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Harvard Ave (HAVAU) had a return on assets of 0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Harvard Ave (HAVAU) had $965K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Harvard Ave (HAVAU) has negative shareholder equity of -$3.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Harvard Ave (HAVAU) has an earnings quality ratio of -1.80x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Harvard Ave (HAVAU) scores 7 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top